Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
International Journal of Cardiology|May 1, 1989
Intravenous diltiazem in patients with paroxysmal re-entrant supraventricular tachycardiaL Frabetti, A Capucci, P S Gerometta, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|August 30, 1983
[Plasma and platelet serotonin in children with essential headache]L Nicoli, M Mambelli, E Scanabissi, et al.
Giornale Italiano Di Cardiologia|October 1, 1984
Epicardial, endocardial and transmural mapping in assessing electrophysiological effects of 14-C lidocaine and 14-C propafenone on activation times in experimental chronic myocardial infarction. Correlations with myocardial drugs concentrationsF F Naccarella, J B Agarwal, W S Weintraub, et al.
Giornale Italiano Di Cardiologia|March 11, 1998
Can exercise testing in patients with a history of myocardial infarction predict fatal and non-fatal reinfarction?G Casella, P C Pavesi, M di Niro, et al.
Heart (British Cardiac Society)|March 1, 1997
Malignant vasovagal syncope: a randomised trial of metoprolol and clonidineM Biffi, G Boriani, P Sabbatani, et al.
Clinical Cardiology|June 1, 1989
Tocainide and metoprolol: an efficacious therapeutic combination in the treatment of premature ventricular beatsA Capucci, L Frabetti, S Gubelli, et al.
Giornale Italiano Di Cardiologia|May 1, 1991
[Significance of the degree of oxidative hepatic metabolism in conditioning the pharmacokinetics and the pharmacodynamics of propafenone]G Boriani, A Capucci, E Strocchi, et al.
Cardiologia (Rome, Italy)|August 1, 1992
[The clinical and prognostic significance of symptomatic and silent ischemia on the exercise test in patients with a prior myocardial infarct]G Casella, P C Pavesi, M Mezzetti, et al.
Cardiologia (Rome, Italy)|January 1, 1995
[Idiopathic atrial fibrillation: clinical-instrumental characterization and thromboembolic risk]G Boriani, A Capucci, V Bruni, et al.
Cardiovascular Drugs and Therapy|February 1, 1990
Minimal effective concentration values of propafenone and 5-hydroxy-propafenone in acute and chronic therapyA Capucci, G Boriani, B Marchesini, et al.
Pageof 8